Expansion Potential Molbio is actively expanding geographically and product portfolio beyond Truenat to digital radiology and pathology, presenting sales opportunities for portable diagnostics, imaging equipment, and related services in new markets and integrated solutions.

Earnings Momentum Recent positive EBITDA and rising revenues indicate improving financial health and capacity for larger procurement deals, making them favorable for large-scale multi-year contracts and enhanced service agreements.

R&D Focus Significant investment in R&D facilities and centers of excellence signals commitment to innovation; potential for co-development partnerships, early-access programs, and customized testing platforms for specific disease panels.

POC Leadership Flagship Truenat real-time PCR platform and ongoing PoC platform development offer upsell opportunities for complementary assays, maintenance contracts, and training services to expand at-point-of-care adoption.

Strategic Growth Plans for acquisitions, alliances, and global footprint expansion create opportunities for channel partnerships, integrator collaborations, and bundled solutions with imaging and diagnostics software.